Horváth, Sándor <br/><br/>
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].  [electronic resource] 

 -  Orvosi hetilap  Dec 2006 
 - 2397-404 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; English Abstract; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0030-6002 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antidepressive Agents, Second-Generation--therapeutic use<br/>Depression--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hungary--epidemiology<br/>Male<br/>Middle Aged<br/>Paroxetine--therapeutic use<br/>Prevalence<br/>Quality of Life<br/>Selective Serotonin Reuptake Inhibitors--therapeutic use<br/>Stroke--psychology<br/>Time Factors<br/>Treatment Outcome